Table 3.
Effect of compound 6n on the active caspases-3, -8 and -9 levels, and the expression levels of Bcl-2, Bax and cytochrome C, respectively, in MCF-7 cancer cells treated with the compound at its IC50 concentration.
Compound | Casp-3 IU/ml | Casp-8 IU/ml | Casp-9 IU/ml | Bax IU/ml | Bcl-2 IU/ml | Bax/Bcl-2 ratio | Cyt-C IU/ml |
---|---|---|---|---|---|---|---|
Control | 1733 | 3368 | 246 | 985 | 178,233 | 0.0055 | 660 |
6n | 131,927*** | 6690** | 228,320*** | 374,152*** | 165,783** | 2.256 | 383,873*** |
Data are mean ± SD of three separate experiments.
Significantly different from control (1% DMSO) at p < .05.
Significantly different from control at p < .01.
Significantly different from control at p < .001.